| abstract |
The invention provides compositions that include conjugates of a carrier molecule, preferably cis-docosahexaenoic acid, and 2',3'-dideoxycytidine. The conjugates are useful in treating viral infections, especially retroviral infections, and particularly reservoirs of viral infection in peripheral T cells and central nervous system manifestations thereof. |